About Exagen Inc.
For more information, please visit Exagen.com and follow @ExagenInc on Twitter.
Investor Relations
rdouglas@exagen.com
760.560.1525
Company
kadawi@exagen.com
Source:
2023 GlobeNewswire, Inc., source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 USD | +6.63% | +9.42% | +5.03% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
About Exagen Inc.
For more information, please visit Exagen.com and follow @ExagenInc on Twitter.
Investor Relations
rdouglas@exagen.com
760.560.1525
Company
kadawi@exagen.com
Source:
2023 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
+5.03% | 34.05M | |
+24.35% | 86.96B | |
-23.35% | 75.65B | |
+0.49% | 26.97B | |
+5.59% | 17.89B | |
-12.27% | 16.58B | |
+3.46% | 15.73B | |
+77.49% | 13.01B | |
+80.40% | 12.92B | |
+38.61% | 12.57B |